Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Financial Statements
Historical financial data — 5 statements covering FY2021–FY2025
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in...
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)'s revenue decreased 1.8% year over year, from $11.23B to $11.03B.
Net income increased 15.6% over the same period, from $1.44B to $1.67B.
Over the 4-year period from FY2021 to FY2025, revenue grew by 16% in total.
Total debt decreased by 15.0% to $8.61B.
The debt-to-equity ratio stands at 0.52, indicating a moderate leverage profile.
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) maintains a healthy net profit margin of 15.1%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2021 | $9.54B | $1.39B | $5.95B | $1.64B | N/A | $34.45B | $166.0M | $26.48B |
| FY2022 | $10.86B+13.8% | $1.06B | $6.58B | $1.82B | N/A | $34.81B | $10.44B | $16.46B |
| FY2023 | $11.30B+4.1% | $1.05B | $6.75B | $2.00B | N/A | $34.05B | $9.46B | $16.73B |
| FY2024 | $11.23B-0.6% | $1.44B | $6.82B | $2.21B | N/A | $34.31B | $10.13B | $16.22B |
| FY2025 | $11.03B-1.8% | $1.67B | $7.08B | $2.41B | N/A | $32.63B | $8.61B | $16.48B |